1
Thomas Karsten Kilvær,
Dagny Førde,
Erna-Elise Paulsen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mehrdad Rakaee
m.fl.:
CD3+RUNX3+ lymphocyte density; an independent prognostic factor in colon and lung adenocarcinoma but not in lung squamous cell carcinoma
Scientific Reports 05. februar 2026
DOI /
ARKIV
1
Falah Jabar Rahim,
Lill-Tove Rasmussen Busund,
Biagio Ricciuti,
Masoud Tafavvoghi,
Thomas Karsten Kilvær,
David J. Pinato
m.fl.:
Fully Automatic Content-Aware Tiling Pipeline for Pathology Whole Slide Images
Intelligence-Based Medicine 01. november 2025
DOI /
ARKIV
1
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Ana Paola Lombardi,
Irene D’arsiè,
Erna-Elise Paulsen
m.fl.:
Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
Frontiers in Oncology 25. september 2025
DOI /
ARKIV
1
Nikita Shvetsov,
Thomas Karsten Kilvær,
Masoud Tafavvoghi,
Anders Sildnes,
Kajsa Møllersen,
Lill-Tove Rasmussen Busund
m.fl.:
A lightweight and extensible cell segmentation and classification model for H&E-stained cancer whole slide images
Computers in Biology and Medicine 27. november 2025
DOI /
ARKIV
1
Nikita Shvetsov,
Anders Sildnes,
Masoud Tafavvoghi,
Lill-Tove Rasmussen Busund,
Stig Manfred Dalen,
Kajsa Møllersen
m.fl.:
Fast TILs—A pipeline for efficient TILs estimation in non-small cell lung cancer
Journal of Pathology Informatics 01. april 2025
DOI /
ARKIV
1
Susanne Ingebrigtsen,
Thomas Karsten Kilvær,
Agnethe Eltoft
:
Adult epilepsy in a North Norwegian County – incidence, prevalence, clinical features, and mortality (2012-2022)
1
Heidi Holmen,
Are Martin Holm,
Ragnhild Sørum Falk,
Thomas Karsten Kilvær,
Tone Marte Ljoså,
Christopher Ekholdt
m.fl.:
A Digital Outpatient Service With a Mobile App for Tailored Care and Health Literacy in Adults With Long-Term Health Service Needs: Multicenter Nonrandomized Controlled Trial
1
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Egil Støre Blix,
Ilona Halva Urbarova,
Erna-Elise Paulsen
m.fl.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
1
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Thomas Karsten Kilvær
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
1
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
m.fl.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
1
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
m.fl.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
1
Hallgeir Selven,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Lill-Tove Rasmussen Busund,
Thomas Karsten Kilvær
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
1
Nikita Shvetsov,
Morten Grønnesby,
Edvard Pedersen,
Kajsa Møllersen,
Lill-Tove Rasmussen Busund,
Ruth Schwienbacher
m.fl.:
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
1
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Roy M. Bremnes,
Thomas Karsten Kilvær
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
1
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
m.fl.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
1
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
m.fl.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
1
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
m.fl.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021
DOI /
ARKIV
1
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
m.fl.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
1
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
m.fl.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
1
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
m.fl.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
1
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
m.fl.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
1
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
m.fl.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
1
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
m.fl.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
1
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Arne Östman,
Carina Strell,
Roy M. Bremnes
m.fl.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
1
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
m.fl.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Cancer Immunology and Immunotherapy 2017
DOI /
ARKIV
1
Samer Al-Saad,
Elin Richardsen,
Thomas Karsten Kilvær,
Tom Dønnem,
Sigve Andersen,
Mehrdad Rakaee
m.fl.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
1
Kaja Skjefstad,
Thea Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
m.fl.:
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
1
Roy M. Bremnes,
Lill-Tove Busund,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen
m.fl.:
The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
Journal of Thoracic Oncology 2016
DOI /
ARKIV
1
Tom Dønnem,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen,
Sigurd Hald
m.fl.:
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
1
Mehrdad Rakaee,
Lill-Tove Busund,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Sigve Andersen
m.fl.:
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
1
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Samer Al-Saad,
Sigurd Hald,
Sigve Andersen
m.fl.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
1
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Mehrdad Rakaee,
Samer Al-Saad,
Ramona Johansen Maurseth,
Khalid Al-Shibli
m.fl.:
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
British Journal of Cancer 2016
DOI /
ARKIV
1
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Turid Hellevik,
Samer Al-Saad,
Erna-Elise Paulsen,
Roy M. Bremnes
m.fl.:
Cancer associated fibroblasts in stage I-IIIA NSCLC: Prognostic impact and their correlations with tumor molecular markers
1
Sigurd Hald,
Yury Kiselev,
Samer Al-Saad,
Elin Richardsen,
Charles Johannessen,
Marte Eilertsen
m.fl.:
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
1
Tom Dønnem,
Sigurd Hald,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Thomas Karsten Kilvær
m.fl.:
Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer
Clinical Cancer Research 2015
DOI /
ARKIV
1
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Ramona Johansen Maurseth,
Samer Al-Saad,
Sigurd Hald
m.fl.:
CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer
1
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigurd Hald,
Tom Wilsgaard,
Roy M. Bremnes,
Lill-Tove Busund
m.fl.:
Lymphangiogenic markers and their impact on nodal metastasis and survival in non-small cell lung cancer - A structured review with meta-analysis
1
Thomas Karsten Kilvær,
Eivind Smeland,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Roy M. Bremnes,
Lill-Tove Busund
m.fl.:
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
1
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Al-Shibli
m.fl.:
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
1
Eivind Smeland,
Thomas Karsten Kilvær,
Sveinung Wergeland Sørbye,
Andrey Yurjevich Valkov,
Sigve Andersen,
Roy M. Bremnes
m.fl.:
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
Susanne Ingebrigtsen,
Agnethe Eltoft,
Thomas Karsten Kilvær
:
Zeroing in: achieving zero complications in lumbar puncture - a quality improvement initiative to reduce complications at the University Hospital of North Norway
BMJ Open Quality 11. juni 2025
DOI /
ARKIV
Mehrdad Rakaee,
Per Niklas Benzler Waaler,
Falah Jabar Rahim,
Krinio Giannikou,
Elio Adib,
Sigve Andersen
m.fl.:
Abstract 5366: DRAGEN pipeline validation for somatic variant detection in diagnostics using TSO500 panel
Cancer Research 21. april 2025
DOI /
ARKIV
M.S. Robertsen,
Per Niklas Benzler Waaler,
Sigve Andersen,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Sissel Gyrid Freim Wahl
m.fl.:
1802P Tissue tumor mutational burden and risk of recurrence in early-stage non-small cell lung cancer
Annals of Oncology 01. september 2025
DOI /
ARKIV
Anne Bergseng,
Nikita Shvetsov,
Thomas Karsten Kilvær
:
Studie: Slik kan AI revolusjonere lungekreftbehandling
VG : Verdens gang 2025
ARKIV
Heidi Holmen,
Are Martin Holm,
Thomas Karsten Kilvær,
Tone Marte Ljoså,
Lars-Petter Ness Granan,
Christopher Ekholdt
m.fl.:
Digital Outpatient Services for Adults: Development of an Intervention and Protocol for a Multicenter Non-Randomized Controlled Trial
Heidi Holmen,
Anna Hurrød,
Christopher Ekholdt,
Are Martin Holm,
Thomas Karsten Kilvær,
Lotte Sandberg Larsen
m.fl.:
Digital outpatient services: development of an intervention and a multicenter controlled trial
Heidi Holmen,
Anna Hurrød,
Christopher Ekholdt,
Are Martin Holm,
Saida Alfrida Martinez Overgaard,
Lotte Sandberg Larsen
m.fl.:
Digital poliklinikk - utvikling av en intervensjon og en multisenterstudie
Kaja Konstanse Skjefstad,
Thea K.W. Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
m.fl.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Sigurd Hald,
Yury Kiselev,
Samer Al-Saad,
Elin Helmine Richardsen,
Charles Walquist Johannessen,
Marte Eilertsen
m.fl.:
Erratum: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. [BMC Cancer. 15, (2015) (441)] DOI: 10.1186/s12885-015-1446-z
Yury Kiselev,
Andrey Yurjevich Valkov,
Lill-Tove Busund,
Roy M. Bremnes,
Igor Snapkov,
Ingvild Mikkola
m.fl.:
Transcription factor PAX6 is expressed in human soft tissue sarcomas and confers negative impact on patients' survival